ArticleThe Kaohsiung journal of medical sciences2023

miR-199a/214 cluster enhances prostate cancer sensitiveness to nimotuzumab via targeting TBL1XR1.

Sheng Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.